695 related articles for article (PubMed ID: 26758997)
1. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
[TBL] [Abstract][Full Text] [Related]
2. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-21 protects human skeletal muscle myotubes from palmitate-induced insulin resistance by inhibiting stress kinase and NF-κB.
Lee MS; Choi SE; Ha ES; An SY; Kim TH; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
Metabolism; 2012 Aug; 61(8):1142-51. PubMed ID: 22398021
[TBL] [Abstract][Full Text] [Related]
4. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
[TBL] [Abstract][Full Text] [Related]
5. Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes.
Kruse R; Vienberg SG; Vind BF; Andersen B; Højlund K
Diabetologia; 2017 Oct; 60(10):2042-2051. PubMed ID: 28721439
[TBL] [Abstract][Full Text] [Related]
6. Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected].
Storgaard H; Song XM; Jensen CB; Madsbad S; Björnholm M; Vaag A; Zierath JR
Diabetes; 2001 Dec; 50(12):2770-8. PubMed ID: 11723060
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.
Xie T; So WY; Li XY; Leung PS
Clin Sci (Lond); 2019 Oct; 133(19):2029-2044. PubMed ID: 31654570
[TBL] [Abstract][Full Text] [Related]
8. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds.
Pérez-Martí A; Sandoval V; Marrero PF; Haro D; Relat J
Horm Mol Biol Clin Investig; 2016 Sep; 30(1):. PubMed ID: 27583468
[TBL] [Abstract][Full Text] [Related]
9. TM-25659-Induced Activation of FGF21 Level Decreases Insulin Resistance and Inflammation in Skeletal Muscle via GCN2 Pathways.
Jung JG; Yi SA; Choi SE; Kang Y; Kim TH; Jeon JY; Bae MA; Ahn JH; Jeong H; Hwang ES; Lee KW
Mol Cells; 2015 Dec; 38(12):1037-43. PubMed ID: 26537193
[TBL] [Abstract][Full Text] [Related]
10. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A
Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
12. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).
Nygaard EB; Møller CL; Kievit P; Grove KL; Andersen B
Int J Obes (Lond); 2014 Feb; 38(2):183-91. PubMed ID: 23736354
[TBL] [Abstract][Full Text] [Related]
13. Dynamic change of serum FGF21 levels in response to glucose challenge in human.
Lin Z; Gong Q; Wu C; Yu J; Lu T; Pan X; Lin S; Li X
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1224-8. PubMed ID: 22539584
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
15. IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle.
Kim TH; Choi SE; Ha ES; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
Acta Diabetol; 2013 Apr; 50(2):189-200. PubMed ID: 21293887
[TBL] [Abstract][Full Text] [Related]
16. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway.
Díaz-Delfín J; Hondares E; Iglesias R; Giralt M; Caelles C; Villarroya F
Endocrinology; 2012 Sep; 153(9):4238-45. PubMed ID: 22778214
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic fibroblast growth factor 21 protects against type 2 diabetes in mice by promoting insulin expression and secretion in a PI3K/Akt signaling-dependent manner.
Pan Y; Wang B; Zheng J; Xiong R; Fan Z; Ye Y; Zhang S; Li Q; Gong F; Wu C; Lin Z; Li X; Pan X
J Cell Mol Med; 2019 Feb; 23(2):1059-1071. PubMed ID: 30461198
[TBL] [Abstract][Full Text] [Related]
18. TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.
Huang S; Ma S; Ning M; Yang W; Ye Y; Zhang L; Shen J; Leng Y
Metabolism; 2019 Oct; 99():45-56. PubMed ID: 31295453
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
[TBL] [Abstract][Full Text] [Related]
20. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
